Previous clinical studies have preliminarily identified neuron-specific enolase (NSE), fibrinogen (FIB), and gastrin-releasing peptide precursor as key protein molecules that influence the treatment efficacy and prognosis of small cell lung cancer (SCLC) patients. This evidence concerns the gene GRP and small cell lung carcinoma.